证券代码：002253 证券简称：*ST 智胜 公告编号：2025-063 四川川大智胜软件股份有限公司 关于转让控股子公司四川华控图形科技有限公司股权的进展公告 近日，公司已收到成都聚兴同行企业管理合伙企业（有限合伙）支付的 股权转让尾款2,006万元。截至本公告日，公司已收到上述交易的全部款项。 公司将密切关注股权变更登记等后续进展情况并及时履行信息披露义务，敬 请广大投资者理性投资，注意投资风险。 特此公告。 四川川大智胜软件股份有限公司 董 事 会 二〇二五年十二月二十七日 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 一、交易概述 四川川大智胜软件股份有限公司（以下简称"公司"）于2025年9月29日 召开第九届董事会第三次临时会议，审议通过《关于转让控股子公司四川华 控图形科技有限公司股权的议案》，同意公司向成都聚兴同行企业管理合伙 企业（有限合伙）转让其持有的四川华控图形科技有限公司44.80%的股权。 具体内容详见公司分别登载于2025年9月30日、2025年10月25日巨潮资讯网、 《中国证券报》《证券时报》《关于转让控股子公司四川华控图形 ...

（文章来源：证券时报网） | 证券代 | 证券简 | 今日涨跌幅 | 今日换手率 | 年线 | 最新价 | 乖离率 | | --- | --- | --- | --- | --- | --- | --- | | 码 | 称 | （%） | （%） | （元） | （元） | （%） | | 603305 | 旭升集 | 10.01 | 8.74 | 14.21 | 15.38 | 8.27 | | | 团 | | | | | | | 600279 | 重庆港 | 10.02 | 2.26 | 5.38 | 5.82 | 8.15 | | 002253 | *ST智胜 | 4.98 | 3.86 | 11.05 | 11.60 | 4.95 | | 920098 | 科隆新 材 | 6.73 | 8.81 | 31.60 | 33.00 | 4.42 | | 603809 | 豪能股 份 | 10.02 | 10.15 | 13.46 | 14.05 | 4.39 | | 600860 | 京城股 份 | 6.07 | 4.16 | 12.07 | 12.59 | 4.32 | | 600892 | *ST大晟 ...

广东信达律师事务所 股东会法律意见书 中国 深圳 福田区益田路6001号太平金融大厦11、12楼 邮政编码：518038 11-12/F, Taiping Finance Tower, Yitian Road 6001, Futian District，Shenzhen, P. R. China 电话(Tel)：(0755)88265288 传真(Fax) ：(0755) 88265537 电子邮件(E-mail)：info@sundiallawfirm.com 网站（Website）：www.sundiallawfirm.com 广东信达律师事务所 关于四川川大智胜软件股份有限公司 现行有效的《四川川大智胜软件股份有限公司章程》（下称"《公司章程》"）的规 定，并基于对《股东会法律意见书》出具日前已经发生或存在事实的调查和了解 发表法律意见。 为出具《股东会法律意见书》，信达律师已严格履行法定职责，遵循了勤勉 尽责和诚实信用原则，审查了公司提供的以下文件，包括但不限于： 1、《公司章程》； 2025 年第四次临时股东会的法律意见书 信达会字[2025]第 402 号 致：四川川大智胜软件股份有限公司 广东信 ...

证券代码：002253 证券简称：*ST 智胜 公告编号：2025-062 四川川大智胜软件股份有限公司 （一）会议召开情况 2025年第四次临时股东会决议公告 1. 会议召开时间：2025年12月22日（星期一）下午2:00 本公司及董事会全体成员保证信息披露内容真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 2. 会议召开地点：成都市武科东一路7号智胜大厦12楼会议室 本次股东会不涉及变更以往股东会已通过的决议 一、会议召开和出席情况 3. 会议召开方式：现场投票与网络投票相结合 4. 会议召集人：公司董事会 特别提示： 本次股东会未出现否决提案的情形 5. 会议主持人：公司董事长游志胜 6. 本次会议符合有关法律、行政法规、部门规章、规范性文件和《公 司章程》的规定。 （二）会议出席情况 通过现场和网络投票出席本次股东会的股东及股东授权代表人共 271人，代表股份数64,401,503股，占公司股份总数的28.5435%。其中： 1. 出席本次股东会现场会议的股东及股东授权代表人共15人，代表股 份数55,828,003股，占公司股份总数的24.7436%； 2. 通过深圳证券交易所交易系统和 ...

证券代码：002253 证券简称：*ST 智胜 公告编号：2025-061 四川川大智胜软件股份有限公司 关于四川省财政厅持有公司股权划转的进展公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误 导性陈述或重大遗漏。 一、本次股权划转的基本情况 本次股权划转完成后，四川振兴集团持有公司 15,724,800 股，持股比例 为 6.97%，为公司第二大股东，四川省财政厅不再持有公司股份。 三、其他说明 本次股权划转不会对公司的正常经营活动产生影响，不会导致公司的控 股股东、实际控制人发生变化。 四川振兴集团成为川大智胜第二大股东后，将遵守《深圳证券交易所股 票上市规则》《上市公司股东减持股份管理暂行办法》等相关规定。 四、备查文件 中国证券登记结算有限责任公司出具的《证券过户登记确认书》。 特此公告。 四川川大智胜软件股份有限公司 董 事 会 四川川大智胜软件股份有限公司（以下简称"公司""川大智胜"）第 二大股东四川省财政厅将其持有的川大智胜 6.97%股份（即 15,724,800 股） 以协议转让的方式划转至四川产业振兴基金投资集团有限公司（以下简称"四 川振兴集团"）。本次 ...

Group 1: Company Announcements - Yongding Co., Ltd. does not directly manufacture controllable nuclear fusion devices but provides materials for the winding magnets of such devices [1] - Aerospace Power's main business does not involve commercial aerospace, nor does it have any commercial aerospace-related assets for external investment [1] - Zhibang Home intends to repurchase company shares worth between 80 million to 110 million yuan [3] Group 2: Investment Projects - Jiangsu Longsheng Weirui plans to invest approximately 350 million yuan to establish an intelligent robot innovation center [1] - Hainan Development's Zhuhai Sanxin plans to invest in the second phase of its production base project in Zhuhai [2] - New Fengming intends to invest 280 million USD to build a 360,000 tons/year functional fiber project in Egypt [2] Group 3: Contracts and Bids - Dayu Irrigation has pre-won the construction project for high-standard farmland in Inner Mongolia's Chifeng City for 2025 [1] - Dayu Irrigation has also pre-won the construction project for high-standard farmland in Inner Mongolia's Tongliao City for 2025 [2] - *ST Zhisheng has won the bid for the smart city governance (Phase IV) project [1] Group 4: Equity Transactions - Rongzi Technology plans to acquire 54.9688% of Guizhou Xinren's shares for 342 million yuan and will also increase its capital [3] - Tiankang Biological intends to purchase 51% equity of Qiangdu Livestock [2] - Binhai Energy plans to acquire 51% equity of Xingtai New Energy [3] Group 5: Share Buybacks and Holdings - Maide Medical plans to spend between 20 million to 40 million yuan to repurchase shares [3] - Tianli Technology's Qian Yongyao intends to reduce his holdings by no more than 3% [3] - Haichuan Intelligent's Wu Guifang and Zheng Xuefen plan to collectively reduce their holdings by no more than 5.98% [3] Group 6: Fundraising Activities - Tianshun Wind Power plans to raise no more than 1.95 billion yuan through a private placement [3] - Leisai Intelligent plans to raise no more than 1.144 billion yuan through a private placement [3]

Group 1 - Moer Thread plans to use up to 7.5 billion yuan of idle raised funds for cash management, with a usage period of 12 months [1] - O-film plans to purchase 8.46% equity of its subsidiary Anhui Che Lian for a total of 3.64 billion yuan, increasing its ownership from 78.54% to 87% [2] - ST Lian Shi applies to revoke the delisting risk warning as its restructuring plan has been completed [3] Group 2 - Weirli signs a strategic cooperation framework agreement with Primech Holdings to build an industrial robot cooperation platform [4] - Race Intelligent plans to raise no more than 1.144 billion yuan through a private placement for core components of intelligent equipment [5] - Renfu Pharmaceutical's stock will be subject to other risk warnings and will be suspended for one day starting December 15 [6] Group 3 - Yongding Co. clarifies that its subsidiary Dongbu Superconductor does not directly manufacture controllable nuclear fusion devices [7] - Rongbai Technology plans to acquire part of Guizhou Xinren's equity and increase its capital to achieve control [9] - ST Hu Ke is under investigation by the Securities Regulatory Commission for suspected information disclosure violations [10] Group 4 - Yunnan Ge Industry plans to establish a subsidiary focused on organic germanium-related products [11] - Greenme intends to acquire 16.38% equity of Henan Recycling Group for 400 million yuan [12] - Jiangzhong Pharmaceutical plans to change its name to China Resources Jiangzhong Pharmaceutical [13] Group 5 - Jiangsu Guoxin's subsidiary Ma Zhou Power has completed the trial operation of a 1,000 MW coal-fired power generation unit [16] - Longsheng Technology plans to invest in a center for embodied intelligent robots [18] - Guangzhou Development has received approval for the registration of 8 billion yuan medium-term notes and 6 billion yuan short-term financing notes [19] Group 6 - China Merchants Port reported a container throughput of 17.248 million TEUs in November, a year-on-year increase of 6.4% [20] - Tianma Technology reported a total eel output of approximately 11,415.87 tons from January to November [21] Group 7 - Xilong Science plans to reduce its stake by up to 1% [22] - Xicet Testing's actual controller plans to transfer 5% of the company's shares [23] - Oppein Home's actual controller plans to increase its stake by 50 million to 100 million yuan [24] Group 8 - Maide Medical plans to repurchase shares worth 20 million to 40 million yuan [25] - Baicheng Pharmaceutical's major shareholder increased its stake by 0.85% [26] - Mengbaihe's major shareholder plans to reduce its stake by up to 1% [27] Group 9 - Xian Dao Ji Dian's shareholder has reduced its stake by 1.70% [28] - Yaxiang Integration's shareholder reduced its stake by 41,400 shares [29] - Zhiwei Intelligent's actual controller has reduced its stake, bringing the total holding to 69% [30] Group 10 - Jincheng Co.'s actual controller plans to reduce its stake by up to 0.97% [31] - Jianghua Micro's chairman has reduced his stake by 1.09% [32] - COSCO Shipping Energy signed a shipbuilding contract worth 7.882 billion yuan [33] Group 11 - Dayu Water Saving's subsidiary is expected to win two high-standard farmland construction projects [34] - Guorui Technology's subsidiary is a candidate for the GXLF project [36] - ST Zhisheng has won a smart city governance project worth 104 million yuan [37]

Group 1 - Shouyao Holdings is planning to issue H-shares and list on the Hong Kong Stock Exchange, with discussions ongoing with intermediaries regarding the specifics of the listing [1] - Jiangsu Guoxin's subsidiary, Guoxin Mazhou, has completed the trial operation of a 1000MW coal-fired power unit, which is set to officially commence operations on December 12, 2025 [2] - Yuekang Pharmaceutical's mRNA tumor vaccine has received clinical trial approval from the National Medical Products Administration for treating advanced solid tumors [3] Group 2 - Dongli New Science plans to invest 666 million yuan in the restructuring of SAIC Hongyan, acquiring approximately 14.66% equity post-restructuring [4] - Longsheng Technology is set to invest approximately 350 million yuan in the establishment of an intelligent robot innovation center in Wuxi [5] - Shangwei Co. has received a government subsidy of 2.212 million yuan, which accounts for 13.53% of its audited net profit for 2024 [6] Group 3 - Anglikang has received drug registration certificates for Diclofenac Sodium Enteric-Coated Tablets and approval for a supplemental application for Sacubitril/Valsartan Sodium Tablets [7] - Guangzhou Development has received acceptance notices for the registration of 8 billion yuan in medium-term notes and 6 billion yuan in short-term financing bonds [8] - Kebo Da plans to increase capital by 21.2 million euros (approximately 174 million yuan) in its wholly-owned subsidiary in Germany [9][10] Group 4 - Changguang Huaxin has received a total of 11.6672 million yuan in government subsidies, including 8.0552 million yuan related to income [11] - Haizheng Pharmaceutical's subsidiary has received a European Pharmacopoeia suitability certificate for its raw material [12] - Qianjin Pharmaceutical's subsidiary has received a drug registration certificate for Lurasidone Hydrochloride Tablets, used for treating schizophrenia [13] Group 5 - Daimai Co. has received a warning letter from the Shanghai Securities Regulatory Bureau due to failure to timely disclose a significant event related to a fire incident [14] - ST Changyao's subsidiary has recently ceased production due to financial difficulties and competitive pressures in the photovoltaic industry [15] - Guodian Power is investing in the construction of a 2×1000MW expansion project at the Ganbi Power Plant, with a total dynamic investment of 7.218 billion yuan [16] Group 6 - Kaichuang International's subsidiary has completed the handover of a tuna purse seine vessel, expected to be operational by 2026 [16] - Tieke Rail plans to sign an energy management agreement for a distributed photovoltaic project, which is expected to save approximately 1.441 million yuan in electricity costs over 25 years [18] - Bailian Co. plans to sign a land compensation agreement with Friendship Logistics, with a total compensation of 103 million yuan [19] Group 7 - Dayu Water-saving's subsidiary has been pre-awarded two high-standard farmland construction projects, with total expected amounts of 137 million yuan and 135 million yuan respectively [20] - Tianma Technology reported a total eel output of approximately 1197.15 tons in November, with sales prices ranging from 53,000 yuan/ton to 89,000 yuan/ton [21] - Guorui Technology's subsidiary has been shortlisted for the GXLF project with a bid of 76 million yuan [22] Group 8 - Qingdao Food's deputy general manager has resigned for personal reasons [23] - Guosheng Zhike plans to use up to 900 million yuan of idle funds for cash management [24] - Guodian Nanrui plans to use up to 23 billion yuan of idle funds for entrusted wealth management [25] Group 9 - Jiahuan Energy plans to merge its wholly-owned subsidiary, Zhejiang Jiahuan Hydrogen Peroxide Co., Ltd., through an overall absorption merger [26] - Ganyue Expressway reported vehicle toll service revenue of 309 million yuan for November [27] - Jinling Hotel's chairman has resigned due to work changes [28] Group 10 - Lisheng Pharmaceutical's subsidiary has received drug registration certificates for Apremilast Tablets [29] - Baotai has received a positive opinion from the European Medicines Agency for Gotenfia® for various inflammatory conditions [30] - ST Zhisheng has been awarded a smart city governance project with a bid amount of 104 million yuan [31] Group 11 - Chenxi Aviation and its related personnel have received administrative regulatory measures from the Shaanxi Securities Regulatory Bureau due to financial reporting issues [32] - Portong Medical has appointed Xia Canglan as the new deputy general manager [33] - Maide Medical plans to repurchase shares with a total amount between 20 million and 40 million yuan [34] Group 12 - Jimin Health plans to establish a joint venture with a total investment of 600 million yuan, focusing on AI and software development [35] - Beilu Pharmaceutical has received a drug registration certificate for Pioglitazone Metformin Tablets [36] - Hainan Mining plans to entrust the overall management of the Shiluo Iron Mine to a construction company for three years, with a total contract amount of approximately 818 million yuan [38] Group 13 - Huiyu Pharmaceutical has received a drug registration certificate for Nicardipine Hydrochloride Injection [39] - Baoland has received a government subsidy of 10 million yuan related to income [40] - Qingdao Port has terminated the acquisition of 100% equity in an oil company and 50% equity in Rizhao Shihua due to regulatory concerns [41]

格隆汇12月12日丨*ST智胜(002253.SZ)公布，收到四川三盈招标代理有限公司发出的《中标通知书》。 公司被确认为"智慧城市治理（四期）项目"中标单位。本次中标金额为103,869,622.24元，占公司2024 年度经审计营业收入的62.82 %。若本项目签订正式合同并顺利实施，将对公司未来合同执行期内的经 营业绩产生积极影响。 ...

人民财讯12月12日电，*ST智胜（002253）12月12日公告，公司近日收到中标通知书，被确认为"智慧 城市治理(四期)项目"中标单位，中标金额为1.04亿元，占公司2024年度经审计营业收入的62.82%。 ...